Huons Global Co., Ltd. (KOSDAQ:084110)

South Korea flag South Korea · Delayed Price · Currency is KRW
63,200
-4,200 (-6.23%)
Apr 28, 2026, 3:30 PM KST
28.85%
Market Cap 771.23B
Revenue (ttm) 847.45B
Net Income (ttm) 28.84B
Shares Out 12.20M
EPS (ttm) 2,360.00
PE Ratio 26.78
Forward PE n/a
Dividend 880.00 (1.31%)
Ex-Dividend Date Apr 2, 2026
Volume 63,859
Average Volume 73,666
Open 69,700
Previous Close 67,400
Day's Range 62,800 - 69,700
52-Week Range 40,800 - 76,700
Beta 0.96
RSI 53.68
Earnings Date May 14, 2026

About Huons Global

Huons Global Co., Ltd. manufactures and sells pharmaceutical products for human health in South Korea and internationally. The company offers oral solid form products in the areas of circulatory system, metabolic, anti-pyretic analgesic anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, other chemotherapeutic, and others; and injections in the areas of anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistami... [Read more]

Sector Healthcare
Founded 1965
Employees 118
Stock Exchange KOSDAQ
Ticker Symbol 084110
Full Company Profile

Financial Performance

In 2025, Huons Global's revenue was 847.45 billion, an increase of 4.18% compared to the previous year's 813.46 billion. Earnings were 28.84 billion, an increase of 11.82%.

Financial Statements

News

There is no news available yet.